论文部分内容阅读
中药复方剂型的改革、改变用药途径,是使病情危重患者得以即时治疗的重要措施。在这方面湖北中医学创用清胆注射液治疗急性胆道感染提供了有益的经验。我院自1978年4月开始应用中药复方制成供静脉注射的“清解静注液”治疗以急性胆道感染为主的急腹症病人并取得较好的疗效。本实验旨在观察清解静注液静脉给药对机体的影响,明确有无不良反应或损害。实验证明,这种中药复方静脉注射液无毒性或损害,临床应用是安全的。现将实验观察报导如下:
The reform of traditional Chinese medicine compound dosage forms and the ways to change medications are important measures for immediate treatment of critically ill patients. In this respect, Hubei Chinese Medicine has provided beneficial experience in the use of Qingdan injection in the treatment of acute biliary tract infections. In April 1978, our hospital began to use the traditional Chinese medicine compound made of intravenous injection of “Qing solution intravenous injection” to treat acute abdomen patients with acute biliary tract infection and achieved better results. The purpose of this experiment was to observe the effect of intravenous injection of Qingjie intravenous fluid on the body and to determine whether there was any adverse reaction or damage. Experiments have shown that this traditional Chinese medicine compound intravenous injection is non-toxic or harmful, and its clinical application is safe. The experimental observations are reported as follows: